Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Melphalan-Based Autologous Transplantation in the Octogenarian Multiple Myeloma Patient Population

Blood (2018) 132 (Supplement 1): 4608.

https://doi.org/10.1182/blood-2018-99-110241

Published: 2018

Journal Articles

Vulnerability Variables Among Octogenarians Myeloma Patients: A Single-Center Analysis in 110 Patients

Maria Gavriatopoulou, Despina Fotiou, Maria Roussou, Magdalini Migkou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Panagiotidis, Dimitra Gika, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, MD PhD, Eftathios Kastritis, Meletios A. Dimopoulos

Blood (2017) 130 (Supplement 1): 3152.

https://doi.org/10.1182/blood.V130.Suppl_1.3152.3152

Published: 2017

Journal Articles

Case series of octogenarians with sickle cell disease

Samir K. Ballas, E. Dianne Pulte, Clarisse Lobo, Gaye Riddick-Burden

Blood (2016) 128 (19): 2367–2369.

https://doi.org/10.1182/blood-2016-05-715946

Published: 2016

Journal Articles

The Bleeding Risk of Vitamin K Antagonists Hardly Increases after the Age of 80 Years: Data from a Large Real-Life Cohort Study

Hilde Kooistra, MD, Agneta Calf, MD, Margriet Piersma-Wichers, MD, Gerbrand Izaks, MD, Nic Veeger, MSc, Karina Meijer, MD PhD

Blood (2015) 126 (23): 891.

https://doi.org/10.1182/blood.V126.23.891.891

Published: 2015

Journal Articles

Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

Meletios A. Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou, Despoina Kalapanida, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Despoina Mparmparoussi, Athanasios Zomas, Dimitra Gika, Zafiris Kartasis, Charis Matsouka, Evangelos Kostis, Sofoklis Kontogiannis, Kostas Konstantopoulos, Efstathios Kastritis, MD

Blood (2014) 124 (21): 4738.

https://doi.org/10.1182/blood.V124.21.4738.4738

Published: 2014

Journal Articles

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Luca Pezzullo, MD, Bianca Serio, MD, Raffaele Fontana, MD,, Idalucia Ferrara, MD, Mariarosaria Sessa, Valentina Giudice, Giancarlo Villani, Monia Rocco, Carmine Selleri, MD

Blood (2013) 122 (21): 5394.

https://doi.org/10.1182/blood.V122.21.5394.5394

Published: 2013

Journal Articles

Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese

Nikhil Jaiswal, Undergraduate Pre-Med, Ahsan Khan, Undergraduate Pre-Med, Zahida Yasin, MD

Blood (2013) 122 (21): 4832.

https://doi.org/10.1182/blood.V122.21.4832.4832

Published: 2013

Journal Articles

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Marie-Christine Kyrtsonis, Panagiotis Repousis, Maria Tsirogianni, MD, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Evangelos Terpos, Konstantinos Zervas

Blood (2011) 118 (21): 5084.

https://doi.org/10.1182/blood.V118.21.5084.5084

Published: 2011

Journal Articles

Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)–An International Study

Meir Wetzler, MD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MD, PhD, Herve Dombret, Hartmut Döhner, Prof. Dr. med., Sylvain Pilorge, Utz Krug, MD, Richard A. Larson, MD, Guido Marcucci, MD, Wolfgang Hiddemann, MD, Thomas Buchner, MD, Clara D. Bloomfield, MD

Blood (2011) 118 (21): 2521.

https://doi.org/10.1182/blood.V118.21.2521.2521

Published: 2011

Journal Articles

Lymphoproliferative Disorders (LPD) in Individuals ≥80 Years of Age–Incidence, Response, and Survival

Fallon O France, G. Chikkappa, MD, Donald Pasquale, MD

Blood (2011) 118 (21): 4945.

https://doi.org/10.1182/blood.V118.21.4945.4945

Published: 2011

Journal Articles

Toxicity and Response Among Octogenarians and Nonagenarians with Diffuse Large B Cell Lymphoma Treated with Rituximab-CHOP Therapy

Scott F Huntington, MD, Mahsa Sharifi, PhD, PharmD, John P Greer, MD, David Morgan, MD, Nishitha Reddy, MD

Blood (2010) 116 (21): 1778.

https://doi.org/10.1182/blood.V116.21.1778.1778

Published: 2010

Journal Articles

Diffuse Large B-Cell Lymphoma in the Very Elderly, a Study of Outcome in Patients Aged 80 and Older.

Cindy Varga, MD, BSC, Sarit E. Assouline, MD

Blood (2009) 114 (22): 1942.

https://doi.org/10.1182/blood.V114.22.1942.1942

Published: 2009

Journal Articles

Anemia in Two Groups of Elderly (65–79 and >/=80) Patients with Chronic Kidney Disease (CKD).

Richard C. Woodman, MD, Behin H. Yektashenas, PharmD, Min Fu, MS, MBA, Mark A. Klausner, MD, William M. McClellan, MD, MPH, FACP

Blood (2004) 104 (11): 3719.

https://doi.org/10.1182/blood.V104.11.3719.3719

Published: 2004

Journal Articles

Treatment of CKD Anemia in Octogenarians: A Comparison of Epoetin Alfa (EPO) in Elderly (65–79; >/=80) and Non-Elderly (<65) Patients.

Jeffrey C. Fink, MD, Behin H. Yektashenas, PharmD, Michael V. Blasi, RPh, Mark A. Klausner, MD, Richard C. Woodman, MD, Robert Provenzano, MD

Blood (2004) 104 (11): 3724.

https://doi.org/10.1182/blood.V104.11.3724.3724

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Melphalan-Based Autologous Transplantation in the Octogenarian Multiple Myeloma Patient Population

Vulnerability Variables Among Octogenarians Myeloma Patients: A Single-Center Analysis in 110 Patients

Case series of octogenarians with sickle cell disease

The Bleeding Risk of Vitamin K Antagonists Hardly Increases after the Age of 80 Years: Data from a Large Real-Life Cohort Study

Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)–An International Study

Lymphoproliferative Disorders (LPD) in Individuals ≥80 Years of Age–Incidence, Response, and Survival

Toxicity and Response Among Octogenarians and Nonagenarians with Diffuse Large B Cell Lymphoma Treated with Rituximab-CHOP Therapy

Diffuse Large B-Cell Lymphoma in the Very Elderly, a Study of Outcome in Patients Aged 80 and Older.

Anemia in Two Groups of Elderly (65–79 and >/=80) Patients with Chronic Kidney Disease (CKD).

Treatment of CKD Anemia in Octogenarians: A Comparison of Epoetin Alfa (EPO) in Elderly (65–79; >/=80) and Non-Elderly (<65) Patients.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only